Valsartan and Hydrochlorothiazide Tablets
Belongs to Category:
The company has production licenses for tablets, capsules, granules, suppositories, powders, injections, oral solutions, dry suspensions, and eye drops.
Product Description
Approval Number:
H20213285
Indications:
It is used for treating mild to moderate essential hypertension when valsartan alone cannot adequately control blood pressure. This product is not suitable for the initial treatment of hypertension.
Administration:
Each tablet of this product contains 80 mg of olmesartan and 12.5 mg of hydrochlorothiazide. When valsartan monotherapy fails to satisfactorily control blood pressure, hydrochlorothiazide 25 mg once-daily can be added to control blood pressure or prevent hypokalemia. The maximum dosage (containing 80 mg of valsartan and 12.5 mg of hydrochlorothiazide) is taken once a day, and the effect can be seen within 2-4 weeks.
Specifications:
80mg/12.5mg × 10/14/28 tablets
The company has production licenses for tablets, capsules, granules, suppositories, powders, injections, oral solutions, dry suspensions, and eye drops.
The main products cover cardiovascular diseases, diabetic complications, anti-tumor, calcium supplementation, digestive system, respiratory system, and orthopedics.
Related Products
Online Message
We will contact you within one business day. Please pay attention to your email.
Mobile Version QR Code
Whatsapp Account
Copyright © 2025 Jiangsu Wangao Pharmaceutical Co., Ltd.